vs
Easterly Government Properties, Inc.（DEA）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Easterly Government Properties, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$91.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 16.4%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 9.6%）
Easterly Government Properties是一家总部位于美国的房地产投资信托企业，主营收购、开发及运营主要出租给美国联邦政府机构的关键任务类商业地产，资产涵盖办公空间、医疗设施、安全专用场地等，服务美国本土多个核心市场的政府客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
DEA vs PBYI — 直观对比
营收规模更大
DEA
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出11.4%
16.4%
两年增速更快
PBYI
近两年复合增速
9.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $91.5M | $75.5M |
| 净利润 | $1.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 1.5% | — |
| 营收同比 | 16.4% | 27.7% |
| 净利润同比 | -56.9% | — |
| 每股收益（稀释后） | $0.36 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DEAPBYI
| Q1 26 | $91.5M | — | ||
| Q4 25 | $87.0M | $75.5M | ||
| Q3 25 | $86.2M | $54.5M | ||
| Q2 25 | $84.2M | $52.4M | ||
| Q1 25 | $78.7M | $46.0M | ||
| Q4 24 | $78.3M | $59.1M | ||
| Q3 24 | $74.8M | $80.5M | ||
| Q2 24 | $76.2M | $47.1M |
净利润DEAPBYI
| Q1 26 | $1.4M | — | ||
| Q4 25 | $4.6M | — | ||
| Q3 25 | $1.2M | $8.8M | ||
| Q2 25 | $4.1M | $5.9M | ||
| Q1 25 | $3.1M | $3.0M | ||
| Q4 24 | $5.5M | — | ||
| Q3 24 | $4.9M | $20.3M | ||
| Q2 24 | $4.6M | $-4.5M |
毛利率DEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | 77.3% | 69.3% | ||
| Q3 25 | 76.0% | 77.7% | ||
| Q2 25 | 77.2% | 76.5% | ||
| Q1 25 | 77.4% | 77.1% | ||
| Q4 24 | 76.1% | 76.4% | ||
| Q3 24 | 77.7% | 63.9% | ||
| Q2 24 | 76.2% | 77.4% |
营业利润率DEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% |
净利率DEAPBYI
| Q1 26 | 1.5% | — | ||
| Q4 25 | 5.3% | — | ||
| Q3 25 | 1.4% | 16.2% | ||
| Q2 25 | 4.8% | 11.2% | ||
| Q1 25 | 4.0% | 6.5% | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 6.5% | 25.2% | ||
| Q2 24 | 6.0% | -9.6% |
每股收益（稀释后）DEAPBYI
| Q1 26 | $0.36 | — | ||
| Q4 25 | $0.09 | $0.26 | ||
| Q3 25 | $0.02 | $0.17 | ||
| Q2 25 | $0.09 | $0.12 | ||
| Q1 25 | $0.07 | $0.06 | ||
| Q4 24 | $0.13 | $0.40 | ||
| Q3 24 | $0.11 | $0.41 | ||
| Q2 24 | $0.11 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.0M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $1.3B | $130.3M |
| 总资产 | $3.4B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资DEAPBYI
| Q1 26 | $2.0M | — | ||
| Q4 25 | $23.4M | $97.5M | ||
| Q3 25 | $4.4M | $94.4M | ||
| Q2 25 | $4.7M | $96.0M | ||
| Q1 25 | $8.5M | $93.2M | ||
| Q4 24 | $19.4M | $101.0M | ||
| Q3 24 | $31.2M | $96.7M | ||
| Q2 24 | $14.8M | $96.8M |
总债务DEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $22.7M | ||
| Q3 25 | $1.6B | $34.0M | ||
| Q2 25 | $1.7B | $45.3M | ||
| Q1 25 | $1.6B | $56.7M | ||
| Q4 24 | $1.6B | $68.0M | ||
| Q3 24 | $1.5B | $79.3M | ||
| Q2 24 | $1.4B | $90.7M |
股东权益DEAPBYI
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $130.3M | ||
| Q3 25 | $1.3B | $115.3M | ||
| Q2 25 | $1.3B | $104.7M | ||
| Q1 25 | $1.3B | $97.1M | ||
| Q4 24 | $1.3B | $92.1M | ||
| Q3 24 | $1.3B | $71.1M | ||
| Q2 24 | $1.3B | $48.5M |
总资产DEAPBYI
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $216.3M | ||
| Q3 25 | $3.4B | $202.9M | ||
| Q2 25 | $3.4B | $194.9M | ||
| Q1 25 | $3.2B | $196.2M | ||
| Q4 24 | $3.2B | $213.3M | ||
| Q3 24 | $3.1B | $220.7M | ||
| Q2 24 | $3.0B | $205.0M |
负债/权益比DEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | 1.26× | 0.17× | ||
| Q3 25 | 1.23× | 0.30× | ||
| Q2 25 | 1.29× | 0.43× | ||
| Q1 25 | 1.20× | 0.58× | ||
| Q4 24 | 1.21× | 0.74× | ||
| Q3 24 | 1.12× | 1.12× | ||
| Q2 24 | 1.07× | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | 0.7% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流DEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | $259.2M | $14.4M | ||
| Q3 25 | $155.0M | $9.7M | ||
| Q2 25 | $38.1M | $14.1M | ||
| Q1 25 | $24.2M | $3.6M | ||
| Q4 24 | $162.6M | $15.6M | ||
| Q3 24 | $57.2M | $11.0M | ||
| Q2 24 | $57.0M | $1.0M |
自由现金流DEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率DEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度DEAPBYI
| Q1 26 | 0.7% | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率DEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | 56.44× | — | ||
| Q3 25 | 127.75× | 1.10× | ||
| Q2 25 | 9.36× | 2.41× | ||
| Q1 25 | 7.73× | 1.21× | ||
| Q4 24 | 29.82× | — | ||
| Q3 24 | 11.76× | 0.54× | ||
| Q2 24 | 12.37× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DEA
| Rental income | $88.6M | 97% |
| Other | $2.3M | 3% |
| Asset management income | $646.0K | 1% |
PBYI
暂无分部数据
